Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of chemotherapy followed
sequentially by gefitinib versus chemotherapy alone in the first line treatment of non-small
cell lung cancer (NSCLC). This study will be conducted in Asian patients who are classified
as 'never smoker' since it is suggested that these patients are more likely to respond
favorably to treatment with gefitinib.